✦ LIBER ✦
229 Anti-IGF1R therapy with dalotuzumab is efficacious in a sub-set of KRAS mutant cetuximab refractory CRC models
✍ Scribed by S. Sathyanarayanan; D.J. Watkins; K. Sykes; S. Howard; E. Valentine; A. Bloecher; E.A. Clark; K. Hsu; D. Cunningham; C. Winter
- Book ID
- 119602910
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 45 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.